Next Science Valuation
| NXS Stock | 0.14 0.00 0.00% |
Next Science seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Next Science from analyzing the firm fundamentals such as Return On Equity of -2.9, current valuation of 47.42 M, and Profit Margin of (0.43) % as well as examining its technical indicators and probability of bankruptcy.
Price Book 3.1791 | Enterprise Value 47.4 M | Enterprise Value Ebitda (11.05) | Price Sales 1.8564 | Forward PE 128.2051 |
Overvalued
Today
Please note that Next Science's price fluctuation is out of control at this time. Calculation of the real value of Next Science is based on 3 months time horizon. Increasing Next Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Next Science's intrinsic value may or may not be the same as its current market price of 0.14, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.14 | Real 0.12 | Hype 0.14 | Naive 0.14 |
The intrinsic value of Next Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Next Science's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Next Science helps investors to forecast how Next stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Next Science more accurately as focusing exclusively on Next Science's fundamentals will not take into account other important factors: Next Science Cash |
|
Next Science Total Value Analysis
Next Science is now projected to have takeover price of 47.42 M with market capitalization of 40.97 M, debt of 2.49 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Next Science fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
47.42 M | 40.97 M | 2.49 M |
Next Science Investor Information
About 52.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.05. Next Science last dividend was issued on the 29th of January 2026. Based on the measurements of operating efficiency obtained from Next Science's historical financial statements, Next Science is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Next Science Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Next Science has an asset utilization ratio of 247.62 percent. This implies that the Company is making USD2.48 for each dollar of assets. An increasing asset utilization means that Next Science is more efficient with each dollar of assets it utilizes for everyday operations.Next Science Ownership Allocation
Next Science maintains a total of 292.63 Million outstanding shares. Next Science holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Next Science Profitability Analysis
The company reported the revenue of 22.82 M. Net Loss for the year was (10.59 M) with profit before overhead, payroll, taxes, and interest of 18.2 M.About Next Science Valuation
The stock valuation mechanism determines Next Science's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Next Science based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Next Science. We calculate exposure to Next Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Next Science's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 18.4 M | 19.4 M |
Additional Tools for Next Stock Analysis
When running Next Science's price analysis, check to measure Next Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Next Science is operating at the current time. Most of Next Science's value examination focuses on studying past and present price action to predict the probability of Next Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Next Science's price. Additionally, you may evaluate how the addition of Next Science to your portfolios can decrease your overall portfolio volatility.